Resurging dengue cases among the Rohingya refugees in Bangladesh amid COVID-19 pandemic: A SouthEast Asia healthcare concern

Mohapatra, Ranjan K.; Kutikuppala, LV Simhachalam; Kudrat‐E‐Zahan, Md.; Mishra, Snehasish; Verma, Sanjeev Kumar; Ramana, K V; Chowdhary, Rashmi

doi:10.1016/j.amsu.2022.104962

Cited by 9 publications

(24 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Twelve including the nine wilayas having common borders with Mali, Senegal, and Algeria are affected. Thus, regional spread of the outbreak cannot be ruled out even against the One‐Health strategy 4,41 . Global spread of RVF has every possibility due to increased human and animal mobility.…”

Section: Discussionmentioning

confidence: 99%

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review

Mohapatra¹,

Kutikuppala

Kandi

et al. 2023

Health Science Reports

Self Cite

View full text Add to dashboard Cite

Background and Aim Rift valley fever (RVF) virus (RVFV) is reportedly steadily circulating in Mauritania being repeated in 1987, 2010, 2012, 2015, and 2020. Mauritania seems a preferred niche for RVF virus due to its persistent outbreak there. Lately, nine Mauritanian wilayas confirmed 47 (23 fatalities with 49% CFR) human cases between August 30 and October 17, 2022. Most of the cases were largely among livestock breeders associated with animal husbandry activities. The review aimed at understanding the origin, cause, and measures to counter the virus. Methods The facts and figures from the various published articles sourced from databases including Pubmed, Web of Science, and the Scopus as also some primary data from health agencies like WHO, CDC, and so forth were evaluated and the efficacy of countermeasures reviewed. Results Among the reported confirmed cases, it was found that 3−70 year age‐group males outnumbered the females. Deaths after fever occurred primarily due to acute hemorrhagic thrombocytopenia. Human infections often occurred through zoonotic transmission mainly through mosquitoes in the population contiguous to cattle outbreak, a conducive site for local RVFV transmission. Many transmission cases were through direct or indirect contact with blood or organs of the infected animal. Conclusion RVFV infection was predominant in the Mauritanian regions bordering Mali, Senegal, and Algeria. High human and domesticated animal density as also the existing zoonotic vectors further contributed to RVF virus circulation. Mauritanian RVF infection data confirmed that RVFV was zoonotic that included small ruminants, cattle, and camel. This observation hints at the role of transborder animal mobility in RVFV transmission. In light of this, preventive approaches with effective surveillance and monitoring system following the One Health model is extremely beneficial for a free and fair healthy world for all.

show abstract

Section: Discussionmentioning

confidence: 99%

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review

Mohapatra¹,

Kutikuppala

Kandi

et al. 2023

Health Science Reports

Self Cite

View full text Add to dashboard Cite

show abstract

“…Monitoring and management measures for Aedes spp. need a lot of attention to protect the population in the region from the most competent vector 2,5 . Transmission rate could be reduced through targeted effective tracking and management approaches 5 .…”

Section: Recommendationsmentioning

confidence: 99%

“…7 The pathogen has more than three different yet similar variants (DENV-1, DENV-2, DENV-3, and DENV-4). 5 Successive episodes of dengue viral infection with different serotypes leave patients at higher risks of developing severe dengue that could include septic shock or respiratory difficulty owing to hypovolemic shock, internal bleeding, organ damage and fatality. An exposure to one serological variant conferred long-term immunity to the homologous serotype but not to the other serotypes.…”

Section: Denguementioning

confidence: 99%

“…Although currently there are no particular therapy for dengue, prompt incident discovery, recognition of a significant disease alarm mechanism, and effective crisis intervention remain essential actionplan to avoid severe illness, mortality, and fatalities reduction to about a percent. 5 The "Region of the Americas" is compiling statistical vaccine candidates against dengue at various clinical trial stages. [8][9][10][11] Of these, Denguvaxia is the first USFDA-approved vaccine for emergency use.…”

Section: Denguementioning

confidence: 99%

See 1 more Smart Citation

Global health concern on the rising dengue and chikungunya cases in the American regions: Countermeasures and preparedness

Mohapatra,

Bhattacharjee,

Desai

et al. 2024

Health Science Reports

Self Cite

View full text Add to dashboard Cite

Background and AimSevere morbidity and mortality due to seasonal infectious diseases are common global public health issues. Vector‐borne viral illnesses like dengue and chikungunya overload the healthcare systems leading to critical financial burden to manage them. There is no effective drug or vaccine currently available to control these two diseases.MethodsThe review was formulated by incorporating relevant reports on chikungunya and dengue in the Americas regions through a comprehensive search of literature that were available on dedicated scientific publication portals such as PubMed, ScienceDirect, and Web of Science.ResultsThe strategies of public health administrations to control largely the mosquito vectors during tropical monsoon seem to be effective. Yet, it seems practically impossible to completely eliminate them. The mosquito vector disseminates the virus via transovarian route thereby internalising the virus through generations, a reason behind reappearing and recurring outbreaks. The numerous factors associated with industrialisation, urbanisation, population density, and easy transboundary movements appear to have contributed to the spread of vectors from an endemic region to elsewhere.ConclusionThe article made a state‐of‐affair comprehensive analysis of the rising dengue and chikungunya cases in the tropics, particularly the tropical Americas, as a human health concern, the countermeasures undertaken and the overall preparedness. The viral transmission is a hard situation to tackle as the vector survives in diverse temperature and ecology, is resistant to insecticides, and the unavailability of drugs. Better vector‐control measures and improved understanding of the reemerging arboviral infections could offer an extended reaction time to counter outbreaks, and minimise associated morbidity/mortality.

show abstract

“…This can place a significant burden on families and the community as a whole. Dengue was first recorded in the year 1964 in Bangladesh in East Pakistan where it was known as Dhaka fever [6,7] . The first official dengue outbreak in Bangladesh was revealed in the year 2000, with 5551 cases and 93 deaths reported [8] .…”

mentioning

confidence: 99%

The recent outbreak of dengue in Bangladesh is a public and global threat to the international communities; what should we do to mitigate it?

Oduoye,

Akilimali,

Mugenyi

et al. 2023

International Journal of Surgery: Global Health

View full text Add to dashboard Cite

show abstract

Resurging dengue cases among the Rohingya refugees in Bangladesh amid COVID-19 pandemic: A SouthEast Asia healthcare concern

Cited by 9 publications

References 11 publications

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review

Rift valley fever (RVF) viral zoonotic disease steadily circulates in the Mauritanian animals and humans: A narrative review

Global health concern on the rising dengue and chikungunya cases in the American regions: Countermeasures and preparedness

The recent outbreak of dengue in Bangladesh is a public and global threat to the international communities; what should we do to mitigate it?

Contact Info

Product

Resources

About